Angina patients with no obstructive CAD had no worse outcomes over 15 years, perhaps because they got the care they needed.

Royal Philips has entered into an agreement to acquire SpectraWAVE, adding AI-powered intravascular imaging and angiography-based physiology technologies to its coronary intervention portfolio. The ...

Philips (NYSE: PHG) announced that it agreed to acquire SpectraWave, a developer of Enhanced Vascular Imaging (EVI) for ...

December 15, 2025Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for ...

The company offers maintenance for its own products and for heavy diagnostic equipment — CT, MRI, and angiography machines ...

Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 100 studies assessing over 365,000 patients. Proven in real-world ...

Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular ...

In November, The Lancet published an international expert consensus review, "Contemporary, non-invasive imaging diagnosis of ...

Transradial artery access for percutaneous coronary intervention is associated with lower bleeding and vascular complications than transfemoral artery access, especially in patients with acute ...

A session at the AHA Scientific Sessions 2025 focused on clinical trials related to cutting edge valve and coronary care.

Use of myocardial blood flow from stress MRI improved diagnosis of chest pain and improved quality of life in patients with ...